Clinical Trial Update: Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updates the efficacy and safety of the valsartan/hydrochlorothiazide combination for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Diovan HCT (valsartan/hydrochlorothiazide)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED